<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>IL22-pathway</title>
    <style>
        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, sans-serif;
            line-height: 1.6;
            color: #333;
            max-width: 900px;
            margin: 0 auto;
            padding: 20px;
            background: #f5f5f5;
        }
        .content {
            background: white;
            padding: 30px;
            border-radius: 8px;
            box-shadow: 0 2px 4px rgba(0,0,0,0.1);
        }
        h1, h2, h3, h4, h5, h6 {
            color: #2c3e50;
            margin-top: 24px;
            margin-bottom: 16px;
        }
        h1 { border-bottom: 2px solid #3498db; padding-bottom: 10px; }
        h2 { border-bottom: 1px solid #ecf0f1; padding-bottom: 8px; }
        code {
            background: #f4f4f4;
            padding: 2px 6px;
            border-radius: 3px;
            font-family: 'Courier New', monospace;
        }
        pre {
            background: #2c3e50;
            color: #ecf0f1;
            padding: 15px;
            border-radius: 5px;
            overflow-x: auto;
        }
        pre code {
            background: none;
            padding: 0;
            color: inherit;
        }
        blockquote {
            border-left: 4px solid #3498db;
            margin-left: 0;
            padding-left: 20px;
            color: #555;
        }
        table {
            border-collapse: collapse;
            width: 100%;
            margin: 20px 0;
        }
        th, td {
            border: 1px solid #ddd;
            padding: 12px;
            text-align: left;
        }
        th {
            background: #3498db;
            color: white;
        }
        tr:nth-child(even) {
            background: #f9f9f9;
        }
        .mermaid {
            text-align: center;
            margin: 30px 0;
            background: white;
            padding: 20px;
            border-radius: 8px;
            border: 1px solid #e0e0e0;
        }
        .mermaid svg {
            max-width: 100%;
            height: auto;
        }
        a {
            color: #3498db;
            text-decoration: none;
        }
        a:hover {
            text-decoration: underline;
        }
        .toc {
            background: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 5px;
            padding: 15px;
            margin-bottom: 20px;
        }
        .toc ul {
            list-style-type: none;
            padding-left: 20px;
        }
        .toc > ul {
            padding-left: 0;
        }
    </style>
    
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        // Initialize mermaid with custom settings
        mermaid.initialize({ 
            startOnLoad: true,
            theme: 'default',
            themeVariables: {
                primaryColor: '#3498db',
                primaryTextColor: '#fff',
                primaryBorderColor: '#2c3e50',
                lineColor: '#333',
                secondaryColor: '#ecf0f1',
                tertiaryColor: '#f39c12'
            },
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    <div class="content">
        <h1 id="pathway-summary-for-il22">Pathway Summary for IL22</h1>
<h2 id="overview">Overview</h2>
<p>Interleukin-22 (IL-22) is a secreted cytokine of the IL-10 family that plays critical roles in innate immunity, tissue repair, and inflammation at barrier surfaces. Unlike most cytokines, IL-22 acts primarily on non-immune cells (epithelial cells, hepatocytes) through the IL-22R1/IL-10RB receptor complex, activating JAK-STAT signaling to promote antimicrobial defense, epithelial proliferation, and tissue regeneration. IL-22 is produced mainly by activated T cells (Th17/Th22) and innate lymphoid cells (ILC3).</p>
<h2 id="core-signaling-pathways">Core Signaling Pathways</h2>
<h3 id="il-22rjak-stat-pathway">IL-22R/JAK-STAT Pathway</h3>
<p>IL-22 binding to IL-22R1/IL-10RB heterodimeric receptor activates JAK1/TYK2, leading to STAT3 phosphorylation (primary), with additional activation of STAT1 and STAT5. Phosphorylated STATs translocate to nucleus to induce antimicrobial peptides, proliferation genes, and tissue repair factors.</p>
<h3 id="tissue-protection-and-regeneration">Tissue Protection and Regeneration</h3>
<p>IL-22 promotes epithelial cell survival and proliferation through:<br />
- Anti-apoptotic protein expression (BCL-2, BCL-xL)<br />
- Cell cycle progression genes<br />
- Stem cell activation and tissue regeneration</p>
<h3 id="antimicrobial-defense">Antimicrobial Defense</h3>
<p>IL-22 induces expression of antimicrobial proteins at barrier surfaces:<br />
- β-defensins, S100 proteins, RegIII family<br />
- Mucins for barrier protection<br />
- Complement components</p>
<h2 id="pathway-diagram">Pathway Diagram</h2>
<div class="mermaid">
graph TD
    A[IL-22: Cytokine] --> B["IL-22R1/IL-10RB: Receptor (Epithelial Cells)"]
    B --> C[JAK1/TYK2: Kinases]
    C -->|phosphorylation| D[STAT3: Primary]
    C -->|phosphorylation| E[STAT1: Secondary]
    C -->|phosphorylation| F[STAT5: Minor]

    G[IL-22BP/IL-22RA2: Soluble Antagonist] --|blocks| A

    D --> H[Nucleus]
    H --> I[Antimicrobial Peptides]
    I --> J[β-defensins, RegIIIγ, S100A7]

    D --> K[Proliferation Genes]
    K --> L[Tissue Repair]

    D --> M[BCL-2, BCL-xL]
    M --> N[Cell Survival]

    O[Th17/Th22 Cells] -->|produce| A
    P[ILC3] -->|produce| A
    Q[IL-23, IL-1β] -->|induce| O

    R[MAPK Pathway] <-.-> C
    S[PI3K/AKT] <-.-> C

    style A fill:#f9f,stroke:#333,stroke-width:2px
    style D fill:#ffd,stroke:#333,stroke-width:1px
</div>

<h2 id="upstream-regulation">Upstream Regulation</h2>
<ul>
<li><strong>Cellular sources</strong>: Th17, Th22, ILC3, γδ T cells, NKT cells</li>
<li><strong>Inducing cytokines</strong>: IL-23, IL-1β, IL-6, TGF-β</li>
<li><strong>Transcription factors</strong>: RORγt, AHR, STAT3 in producing cells</li>
<li><strong>Negative regulation</strong>: IL-22BP soluble receptor antagonist</li>
</ul>
<h2 id="downstream-effects">Downstream Effects</h2>
<h3 id="antimicrobial-response">Antimicrobial Response</h3>
<ul>
<li><strong>Defensins</strong>: HBD2, HBD3</li>
<li><strong>S100 proteins</strong>: S100A7, S100A8/9</li>
<li><strong>RegIII family</strong>: RegIIIα, RegIIIγ</li>
<li><strong>Lipocalin-2</strong>: Iron sequestration</li>
</ul>
<h3 id="tissue-repair">Tissue Repair</h3>
<ul>
<li><strong>Proliferation markers</strong>: Ki67, PCNA</li>
<li><strong>Wound healing factors</strong>: MMP1, MMP3</li>
<li><strong>Mucins</strong>: MUC1, MUC3, MUC10, MUC13</li>
</ul>
<h3 id="metabolic-effects">Metabolic Effects</h3>
<ul>
<li><strong>Hepatocytes</strong>: Acute phase proteins</li>
<li><strong>Lipid metabolism</strong>: Apolipoprotein regulation</li>
<li><strong>Glucose metabolism</strong>: Affects insulin sensitivity</li>
</ul>
<h2 id="clinical-significance">Clinical Significance</h2>
<h3 id="protective-roles">Protective Roles</h3>
<ul>
<li><strong>Inflammatory bowel disease</strong>: Epithelial repair</li>
<li><strong>Psoriasis</strong>: Paradoxical protective/pathogenic roles</li>
<li><strong>Infections</strong>: Defense against extracellular bacteria</li>
</ul>
<h3 id="pathogenic-roles">Pathogenic Roles</h3>
<ul>
<li><strong>Psoriasis</strong>: Excessive keratinocyte proliferation</li>
<li><strong>Rheumatoid arthritis</strong>: Synovial inflammation</li>
<li><strong>Cancer</strong>: Tumor-promoting in some contexts</li>
</ul>
<h2 id="regulatory-mechanisms">Regulatory Mechanisms</h2>
<ul>
<li><strong>IL-22BP</strong>: Natural antagonist controlling IL-22 activity</li>
<li><strong>Tissue distribution</strong>: Receptor expression limited to non-hematopoietic cells</li>
<li><strong>SOCS proteins</strong>: Negative feedback on STAT signaling</li>
<li><strong>Context-dependent</strong>: Protective vs pathogenic based on timing/amount</li>
</ul>
<h2 id="tissue-specific-functions">Tissue-Specific Functions</h2>
<ul>
<li><strong>Intestinal epithelium</strong>: Barrier integrity, antimicrobial defense</li>
<li><strong>Skin</strong>: Keratinocyte proliferation, wound healing</li>
<li><strong>Liver</strong>: Hepatoprotection, acute phase response</li>
<li><strong>Lung</strong>: Epithelial repair, antimicrobial immunity</li>
<li><strong>Pancreas</strong>: β-cell protection</li>
</ul>
<h2 id="integration-with-immune-networks">Integration with Immune Networks</h2>
<ul>
<li><strong>Type 3 immunity</strong>: Core effector cytokine with IL-17</li>
<li><strong>Th17/ILC3 axis</strong>: Barrier surface immunity</li>
<li><strong>Microbiome interaction</strong>: Maintains host-microbe homeostasis</li>
<li><strong>Tissue-immune crosstalk</strong>: Bridge between immune and stromal cells</li>
</ul>
    </div>
    <footer style="text-align: center; padding: 20px; color: #666;">
        <small>Generated from IL22-pathway.md</small>
    </footer>
</body>
</html>